Inventor
DE CEUNINCK FRÉDÉRIC ANDRÉ
FR6 patents
Patents
6 patentsUS9926281B2Mar 27, 2018
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV6 citations81
US10487060B2Nov 26, 2019
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV4 citations70
US11718588B2Aug 8, 2023
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV0 citations59
US10941117B2Mar 9, 2021
5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV0 citations59
US10829478B2Nov 10, 2020
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis
GALAPAGOS NV0 citations37
US10550100B2Feb 4, 2020
5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis
GALAPAGOS NV0 citations37